ImetelChat

sdrawkcabeman via Yahoo Finance The story of Azacitidine parallels Imetelstat In 2004, Pharmion’s hypomethylating agent, Azacitidine, was the first drug approved by the FDA for all subtypes of MDS. Celgene bought Pharmion for $2.9 billion in 2008. Meanwhile, Celgene had gotten approval by the FDA fo...

BP- i am priveledged to have the smart minds of this board to set me straight and sincerely appreciate the response from you and Fish. I should clarify that the JS statements I quoted were in response to Stifel’s Alex Schwartz question regarding the need for a P3 in MF. As I see it, JS was only talk...

Reflecting and contemplating. JS stated two things that have me pondering Imetelstat might be going for EMA Prime in MF. ‘we haven’t reached the median OS yet. How that will play out regulatorily will demand really some careful thought around the world and also probably some level of interaction wit...

Fish- thanks for posting on SA. Glad you are watching. I’ve watched this board for more years then I care to admit. I appreciate all you have done and for keeping this board alive. You didn’t deserve the SA antogonism. Hope all is OK. BP- thank you helping out in this board and your insight. I look ...